评估腹腔透析中死亡风险的生物标志物轨迹:专注于多变量联合建模
Merve Basol Goksuluk1, Dincer Goksuluk1,2, Murat Hayri Sipahioglu3
1Department of Biostatistics, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
PloS one
|July 28, 2025
概括
先进的统计模型通过分析纵向生物标志物数据,准确预测腹透析 (PD) 患者的死亡风险. 综合生物标志物关系的多变量联合模型为个性化医学提供了优越的风险分层.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
背景情况:
- 腹腔透析 (PD) 是末期病的重要治疗方法.
- 准确预测PD患者的死亡风险对于有效的临床管理至关重要.
- 传统的生存分析方法可能无法完全捕捉纵向生物标志物数据的复杂性.
研究的目的:
- 为了比较传统和先进的统计方法来预测PD患者的死亡风险.
- 评估纵向生物标志物分析对增强风险分层的有用性.
- 确定关键的生物标志物及其与PD所有原因死亡率相关的时间动态.
主要方法:
- 对417名PD患者 (1995-2016) 的回顾性队列研究.
- 对纵向生物标志物的分析:血清白蛋白,肌,,血尿素 (BUN) 和.
- 考克斯比例危险模型,时间依赖共变量和单变量/多变量联合模型的比较.
主要成果:
- 多变量联合模型证明了所有原因死亡率的最高预测准确性.
- 血清白蛋白是最一致的预测因素;肌和显示出特定环境的意义.
- 联合模型有效地整合了纵向数据和生物标志物之间的关系,优于其他方法.
结论:
- 先进的关节建模技术改善了PD患者的死亡风险预测.
- 整合时间生物标志物变化和相互依赖性可以增强生存分析和临床决策.
- 这些动态预测能力支持慢性病管理中的个性化医疗方法.
相关概念视频
Kaplan-Meier Approach
270
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
270
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
108
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
108
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Assumptions of Survival Analysis
198
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198
Mechanistic Models: Compartment Models in Individual and Population Analysis
87
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
87
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
126
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
126


